Cryo Cell International (CCEL) Cash & Current Investments (2010 - 2026)

Cryo Cell International (CCEL) has 17 years of Cash & Current Investments data on file, last reported at $2.9 million in Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $2.9 million, down 16.65% year-over-year; the trailing twelve-month figure through Feb 2026 was $2.9 million (down 16.65% YoY), and the FY2025 annual result was $3.3 million, down 5.72% from the prior year.
• Cash & Current Investments slipped to $2.9 million in Q1 2026 per CCEL's latest filing, from $3.3 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $4.4 million in Q2 2025 and troughed at $979593.0 in Q1 2024.
• A 5-year average of $2.5 million and a median of $2.6 million in 2022 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2022 and 2024: Cash & Current Investments slumped 79.35% in 2022, then surged 256.66% in 2024.
• A 5-year view of Cash & Current Investments shows it stood at $1.7 million in 2022, then slumped by 43.06% to $980250.0 in 2023, then surged by 256.66% to $3.5 million in 2024, then declined by 5.72% to $3.3 million in 2025, then fell by 12.01% to $2.9 million in 2026.
• Business Quant data shows CCEL's Cash & Current Investments at $2.9 million in Q1 2026, $3.3 million in Q4 2025, and $3.2 million in Q3 2025.